Molony DA - Search Results

1

Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States.

Stack AG, Murthy BV, Molony DA. Stack AG, et al. Among authors: molony da. Kidney Int. 2004 Jun;65(6):2398-408. doi: 10.1111/j.1523-1755.2004.00654.x. Kidney Int. 2004. PMID: 15149353

2

Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.

Di Iorio B, Molony D, Bell C, Cucciniello E, Bellizzi V, Russo D, Bellasi A; INDEPENDENT Study Investigators. Di Iorio B, et al. Am J Kidney Dis. 2013 Oct;62(4):771-8. doi: 10.1053/j.ajkd.2013.03.023. Epub 2013 May 16. Am J Kidney Dis. 2013. PMID: 23684755 Clinical Trial.

3

Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.

Ruggeri M, Bellasi A, Cipriani F, Molony D, Bell C, Russo D, Di Iorio B. Ruggeri M, et al. J Nephrol. 2015 Oct;28(5):593-602. doi: 10.1007/s40620-014-0122-8. Epub 2014 Jul 16. J Nephrol. 2015. PMID: 25027030 Clinical Trial.

4

Evidence-based practice in nephrology: critical appraisal of nephrology clinical research: were the correct statistical tests used?

Podoll AS, Bell CS, Molony DA. Podoll AS, et al. Among authors: molony da. Adv Chronic Kidney Dis. 2012 Jan;19(1):27-33. doi: 10.1053/j.ackd.2012.01.004. Adv Chronic Kidney Dis. 2012. PMID: 22364798 Review.

5

Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence.

Samuels JA, Molony DA. Samuels JA, et al. Among authors: molony da. Adv Chronic Kidney Dis. 2012 Jan;19(1):40-6. doi: 10.1053/j.ackd.2012.01.009. Adv Chronic Kidney Dis. 2012. PMID: 22364800 Review.

6

Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura.

Samuel JP, Bell CS, Molony DA, Braun MC. Samuel JP, et al. Among authors: molony da. Clin J Am Soc Nephrol. 2011 Aug;6(8):2034-40. doi: 10.2215/CJN.01410211. Epub 2011 Jun 23. Clin J Am Soc Nephrol. 2011. PMID: 21700827 Free PMC article.

7

Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.

Molony DA, Stephens BW. Molony DA, et al. Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004. Adv Chronic Kidney Dis. 2011. PMID: 21406297 Review.

8

Accumulation of metals and minerals from phosphate binders.

Molony DA, Murthy B. Molony DA, et al. Blood Purif. 2005;23 Suppl 1:2-11. doi: 10.1159/000083712. Blood Purif. 2005. PMID: 15832017 Review.

9

Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race.

Murthy BV, Molony DA, Stack AG. Murthy BV, et al. Among authors: molony da. J Am Soc Nephrol. 2005 Mar;16(3):782-90. doi: 10.1681/ASN.2004080627. Epub 2005 Jan 26. J Am Soc Nephrol. 2005. PMID: 15677309

10

Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.

Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Samuels JA, et al. Among authors: molony da. Nephrology (Carlton). 2004 Aug;9(4):177-85. doi: 10.1111/j.1440-1797.2004.00255.x. Nephrology (Carlton). 2004. PMID: 15363047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results